Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 660,241,800
  • Shares Outstanding, K 9,750
  • 60-Month Beta 0.70
Trade IHE with:
  • Price/Earnings ttm 16.55
  • Annual Dividend & Yield 1.61 (2.37%)
  • Most Recent Dividend 0.294 on 06/11/24
  • Management Fee 0.39%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 1.46% ( +1.46%)
  • Historical Volatility 10.65%
  • IV Percentile 6%
  • IV Rank 0.00%
  • IV High 24.11% on 04/25/24
  • IV Low 1.46% on 07/17/24
  • Put/Call Vol Ratio 0.31
  • Today's Volume 34
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 81
  • Open Int (30-Day) 117

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.37 +3.81%
on 07/05/24
69.53 -2.39%
on 07/17/24
+1.53 (+2.31%)
since 06/18/24
3-Month
62.67 +8.27%
on 04/25/24
69.53 -2.39%
on 07/17/24
+4.84 (+7.68%)
since 04/19/24
52-Week
55.36 +22.57%
on 10/31/23
69.56 -2.44%
on 02/23/24
+8.91 (+15.12%)
since 07/19/23

Most Recent Stories

More News
Bristol-Myers Squibb's Q2 2024 Earnings: What to Expect

Bristol-Myers Squibb is poised to announce its second-quarter results this month, and analysts forecast a single-digit decline in the company’s bottom-line figure.

BMY : 42.64 (+0.59%)
$SPX : 5,505.00 (-0.71%)
IHE : 67.86 (+0.27%)
How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?

Johnson & Johnson has recently underperformed other pharmaceutical stocks. However, Wall Street analysts are moderately optimistic about the stock’s prospects.

JNJ : 154.69 (-0.47%)
PFE : 29.97 (+0.88%)
IHE : 67.86 (+0.27%)
Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

LLY : 857.47 (+1.01%)
$SPX : 5,505.00 (-0.71%)
IHE : 67.86 (+0.27%)
Are Wall Street Analysts Bullish on Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain cautious about the stock's prospects.

VTRS : 11.84 (+0.59%)
$SPX : 5,505.00 (-0.71%)
IHE : 67.86 (+0.27%)
Are Wall Street Analysts Bullish on Johnson & Johnson Stock?

As Johnson & Johnson trails the broader market, Wall Street analysts remain cautiously optimistic about the stock's prospects.

JNJ : 154.69 (-0.47%)
$SPX : 5,505.00 (-0.71%)
IHE : 67.86 (+0.27%)
C : 65.14 (+0.39%)
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Bristol-Myers Squibb stock has significantly trailed the broader market this year, and Wall Street remains wary on the stock’s prospects.

BMY : 42.64 (+0.59%)
$SPX : 5,505.00 (-0.71%)
IHE : 67.86 (+0.27%)
Worried About the Stock Market? Here Are 2 Safe Investments to Buy and Hold for Decades

These ETFs can balance stability and long-term growth.

IHE : 67.86 (+0.27%)
MOAT : 88.25 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

3rd Resistance Point 68.95
2nd Resistance Point 68.67
1st Resistance Point 68.26
Last Price 67.86
1st Support Level 67.58
2nd Support Level 67.29
3rd Support Level 66.89

See More

52-Week High 69.56
Last Price 67.86
Fibonacci 61.8% 64.14
Fibonacci 50% 62.46
Fibonacci 38.2% 60.79
52-Week Low 55.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar